Category: OTCMKTS:TKPYY

Takeda Acquisition Of Shire May Bode Well For R&D Staff

“We think that the fit is very strong between Takeda and Shire. We foresee minimal disruption on the R&D front.”

Tax Reform No Shot In Arm For Pharma Deals

Divests are plentiful but mega-deals lag.